-
-
-
-
Bicyclic compounds
-
Patent number 12,103,902
-
Issue date Oct 1, 2024
-
VIVACE THERAPEUTICS, INC.
-
Andrei W. Konradi
-
C07 - ORGANIC CHEMISTRY
-
-
Heterocyclic compound
-
Patent number 12,071,434
-
Issue date Aug 27, 2024
-
Takeda Pharmaceutical Company Limited
-
Yuhei Miyanohana
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
-
-
Bromodomain inhibitors
-
Patent number 11,884,680
-
Issue date Jan 30, 2024
-
Celgene Quanticel Research, Inc.
-
Amogh Boloor
-
C07 - ORGANIC CHEMISTRY
-
-
-
Compounds and uses
-
Patent number 11,840,543
-
Issue date Dec 12, 2023
-
The University of Queensland
-
Luke O'Neill
-
C07 - ORGANIC CHEMISTRY
-
-
-
Substituted bicyclic compounds
-
Patent number 11,701,373
-
Issue date Jul 18, 2023
-
Bristol-Myers Squibb Company
-
Alaric J. Dyckman
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
-
-
Bromodomain inhibitor
-
Patent number 11,679,106
-
Issue date Jun 20, 2023
-
Celgene Quanticel Research, Inc.
-
Juan Manual Betancort
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
-
-
-
-
-
-
Bicyclic compounds
-
Patent number 11,420,935
-
Issue date Aug 23, 2022
-
VIVACE THERAPEUTICS, INC.
-
Andrei W. Konradi
-
C07 - ORGANIC CHEMISTRY
-
-
Bicyclic compounds
-
Patent number 11,384,049
-
Issue date Jul 12, 2022
-
VIVACE THERAPEUTICS, INC.
-
Andrei W. Konradi
-
C07 - ORGANIC CHEMISTRY
-
-
-